Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:affiliatedWith |
vinca alkaloid
|
| gptkbp:approvedBy |
gptkb:FDA
1963 |
| gptkbp:ATCCode |
L01CA02
|
| gptkbp:brand |
gptkb:vincristine
gptkb:Vincasar_PFS |
| gptkbp:chemicalFormula |
C46H56N4O10
|
| gptkbp:contraindication |
gptkb:Charcot-Marie-Tooth_disease
|
| gptkbp:discoveredBy |
gptkb:Eli_Lilly_and_Company
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oncovin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits microtubule formation
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
constipation
hair loss peripheral neuropathy bone marrow suppression |
| gptkbp:usedFor |
gptkb:cancer
leukemia multiple myeloma |
| gptkbp:bfsParent |
gptkb:vincristine
|
| gptkbp:bfsLayer |
6
|